All News


All series


All All News

When Dale Eastman was diagnosed with stage 3 breast cancer in 1990 at age 49, it turned the travel agent and mother into a driven advocate.

For ER-positive breast cancer, researchers look to find which drugs work best, how they should be sequenced, and how long they should be taken.

Bone Drug in Limbo

The FDA decides to wait on reviewing Prolia (denosumab) for reducing treatment-related bone loss in breast and prostate cancer patients, but a new study may shed light on the drug’s importance.